The Influenza Division (ID) improves global control and prevention of seasonal and novel influenza and improves influenza pandemic preparedness and response. In collaboration with domestic and global partners, the ID:
- Builds surveillance and response capacity.
- Monitors and assesses influenza viruses and illness.
- Improves vaccines and other interventions.
- Applies research to provide science-based enhancement of prevention and control policies and programs.
What We Do
Office of the Director
- Provides vision, leadership and direction for the flu division.
- Fosters external partnerships and cross-cutting activities that support quality science and strong global partnerships.
- Provides leadership and guidance in policy formulation.
- Provides support for national and international capacity building programs.
- Provides technical expertise and leadership for national and international pandemic preparedness activities.
- Provides technical expertise for communications, information technology, genomic sequencing, and reagent resources.
Virology, Surveillance, and Diagnosis Branch
David Wentworth, Ph.D. – Acting Branch Chief
- Conducts comprehensive antigenic, phenotypic, genotypic, structural and evolutionary characterization of human and animal influenza viruses.
- Performs genetic and antigenic pandemic risk assessment of novel influenza viruses.
- Develops and evaluates novel and seasonal candidate vaccine viruses.
- Provides expert guidance on influenza vaccine virus selection.
- Develops methods to detect and characterize influenza viruses.
- Trains and supports laboratories that perform influenza testing.
- Conducts surveillance and research activities to better understand the epidemiology of influenza.
- Improves understanding of the effectiveness of influenza antiviral and vaccine programs.
Immunology and Pathogenesis Branch
- Increases knowledge and improves understanding of immunity and immune correlates of protection.
- Develops and improves vaccines.
- Determines virus and host factors that impact virulence and transmission of influenza viruses.
- Conducts immunologic and virologic pandemic risk assessment of novel influenza viruses.
- Trains and supports laboratories that perform immunologic testing.
For more information on influenza please visit the Seasonal Flu web site.
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.